Page last updated: 2024-09-03

s 11568 and cyclic gmp

s 11568 has been researched along with cyclic gmp in 1 studies

Compound Research Comparison

Studies
(s 11568)
Trials
(s 11568)
Recent Studies (post-2010)
(s 11568)
Studies
(cyclic gmp)
Trials
(cyclic gmp)
Recent Studies (post-2010) (cyclic gmp)
160022,3463334,062

Protein Interaction Comparison

ProteinTaxonomys 11568 (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biondi, ML; Feletou, M; Peglion, JL; Vanhoutte, PM; Vilaine, JP; Villeneuve, N1

Other Studies

1 other study(ies) available for s 11568 and cyclic gmp

ArticleYear
The calcium channel antagonist S 11568 causes endothelium-dependent relaxation in canine arteries.
    European journal of pharmacology, 1991, May-02, Volume: 197, Issue:1

    Topics: Animals; Arginine; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Dogs; Endothelium, Vascular; Female; Hemoglobins; In Vitro Techniques; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine

1991